- Home
- NWN vs SRPT Comparison
NWN vs SRPT Comparison
Compare NWN & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWN
- SRPT
- Stock Information
- Founded
- NWN 1859
- SRPT 1980
- Country
- NWN United States
- SRPT United States
- Employees
- NWN N/A
- SRPT N/A
- Industry
- NWN Oil/Gas Transmission
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- NWN Utilities
- SRPT Health Care
- Exchange
- NWN Nasdaq
- SRPT Nasdaq
- Market Cap
- NWN 1.7B
- SRPT 1.9B
- IPO Year
- NWN N/A
- SRPT 1997
- Fundamental
- Price
- NWN $46.00
- SRPT $23.45
- Analyst Decision
- NWN Buy
- SRPT Hold
- Analyst Count
- NWN 2
- SRPT 30
- Target Price
- NWN $48.00
- SRPT $36.56
- AVG Volume (30 Days)
- NWN 229.7K
- SRPT 5.4M
- Earning Date
- NWN 11-05-2025
- SRPT 11-03-2025
- Dividend Yield
- NWN 4.26%
- SRPT N/A
- EPS Growth
- NWN 17.48
- SRPT N/A
- EPS
- NWN 2.58
- SRPT N/A
- Revenue
- NWN $1,238,288,000.00
- SRPT $2,481,531,000.00
- Revenue This Year
- NWN $17.95
- SRPT $9.68
- Revenue Next Year
- NWN $5.66
- SRPT N/A
- P/E Ratio
- NWN $17.83
- SRPT N/A
- Revenue Growth
- NWN 8.40
- SRPT 64.89
- 52 Week Low
- NWN $38.03
- SRPT $10.42
- 52 Week High
- NWN $47.79
- SRPT $138.81
- Technical
- Relative Strength Index (RSI)
- NWN 56.41
- SRPT 58.16
- Support Level
- NWN $46.76
- SRPT $21.29
- Resistance Level
- NWN $47.77
- SRPT $24.38
- Average True Range (ATR)
- NWN 0.81
- SRPT 1.09
- MACD
- NWN 0.01
- SRPT -0.01
- Stochastic Oscillator
- NWN 56.72
- SRPT 73.25
About NWN Northwest Natural Holding Company
Northwest Natural Holding Co is a public natural gas service supplier operating in the U.S. Pacific Northwest. Its subsidiary, NW Natural, operates through the natural gas distribution segment, which purchases and distributes natural gas through which operates in Oregon and southwest Washington. The company operates in one reportable business segment, which is NW Natural's local gas distribution business and is referred to as the NGD segment. The company generates its revenue from residential, commercial, and industrial customers, the majority of which are in Oregon. Residential and commercial customers account for the vast majority of profitability.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.